Murine RNase Inhibitor is purified from a recombinant strain of E. coli in a soluble form. It specifically inhibits the activity of RNases A, B and C through binding noncovalently in a 1:1 ratio with high affinity. This product can be compatible with Hifair™ V Reverse Transcriptase and various DNA polymerases verified by RT-PCR and RT-qPCR. Recombinant murine RNase inhibitor does not contain 2 oxidation-sensitive cysteine which are contained in human-origin RNase inhibitor. Therefore, Murine RNase inhibitor has high anti-oxidation activity and is more stable for low DTT experiments (< 1mmol/L), such as qPCR.

Compared with Murine RNase Inhibitor (40 U/µL) (Cat#10603ES), The host nucleic acid residue of UCF.ME™ Murine RNase Inhibitor (40 U/µL) is lower，which is suitable for application with more stringent requirements on background bacteria, such as pathogen detection.

Specifications

Components

Storage

This product should be stored at -25~-15℃ for 18 months.

Instructions

1. The recommended amount to add in a 20 μL system is 40 units (U), and the input quantity can be adjusted based on the actual results.

2. Incubate at 42℃ for 45 min, and inactivate the reaction by heating at 85℃ for 5 min.

Notes

1. The product works in a wide pH range and exhibits maximal inhibitory activity at pH 7~8.

2. Please handle the product gently to avoid inactivation.

3. This product does not inhibit RNase H.

4. For your safety and health, please wear lab coats and disposable gloves for operation.

Figures

01 No DNA nuclease and RNase was detected

Figure 1. Detection of nuclease, nicking enzyme, and RNase residuals in UCF.ME™ Murine RNase Inhibitor.

Note: N represents the negative control; 1, 2, 3 represent three sets of parallel experiments.

02 E. coli genomic DNA residue is less than 0.1 copies/100 U, significantly lower than the conventional version.

Conducting host (E.coli) genomic DNA residue detection on different batches of UCF.ME^TM Murine RNase Inhibitor and comparing it with the host residue levels of conventional Murine RNase inhibitors, the results show that the host genomic DNA residue of UCF.ME^TM Murine RNase Inhibitor is below 0.1 copies/100 U, significantly lower than that of the conventional version.

  Figure 2: Comparison of E. coli genomic residue detection results between 

UCF.ME^TM MRI and conventional MRI.

03 The RNase inhibitory capability is significantly superior to that of imported brands.

Using Total RNA as a template, the RT-qPCR reaction was conducted using the Hifair^TM V Multiplex One Step RT-qPCR Probe Kit (UDG Plus) (Cat#13650ES) to verify the RNaseA digestion capability of UCF.ME^TM Murine RNase Inhibitor. The results indicated that the inhibitory effect of Yeasen UCF.ME MRI on RNaseA is significantly superior to that of similar international competitive products.

Figure 3: Validation of RNase Inhibition Capability of UCF.ME™ MRI

Note: Yeasen UCF MRI: 8 U UCF.ME™ MRI + 80 ng RNaseA; Yeasen MRI: 8 U MRI + 80 ng RNaseA; Competitor N*: 8 U of a similar competitive product + 80 ng RNaseA; Control: No MRI and RNaseA.